Voltar
Carta Acesso aberto Revisado por pares
BIBTEX RIS

Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases

2016; Taylor & Francis; Volume: 16; Issue: 10 Linguagem: Inglês

10.1080/14712598.2016.1198765

ISSN

1744-7682

Autores

Stefano Gentileschi, Cristiana Barreca, Francesca Bellisai, Giovanni Biasi, Maria Giuseppina Brizi, Renato De Stefano, Marta Fabbroni, Antonella Fioravanti, Elena Frati, Enrico Selvi, Antonio Vitale, Luca Cantarini, Bruno Frediani, Mauro Galeazzi,

Tópico(s)

Health Systems, Economic Evaluations, Quality of Life

Resumo

"Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases." Expert Opinion on Biological Therapy, 16(10), pp. 1311–1312

Referência(s)